Pulmonary Hypertension Trial, Recruiting (NCT04071327)

Pulmonary Hypertension Trial, Recruiting NCT04071327 Sponsor: Pulmonary Hypertension Association, Inc. Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT04071327 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any age are welcome to participate.
Written consent to take part in the trial must be provided (for children, a parent or guardian would typically provide this).
People who have been diagnosed with pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH), or pulmonary hypertension in children caused by abnormal lung development.
People who have had their first outpatient appointment at a Pulmonary Hypertension Care Centre within the last 6 months.

Who may not be able to join:

People whose pulmonary hypertension is classified as World Symposium on Pulmonary Hypertension (WSPH) Group 2, which generally refers to high lung blood pressure caused by left-sided heart disease (confirm with trial site).
People whose pulmonary hypertension is classified as WSPH Group 3, which generally refers to high lung blood pressure caused by lung disease or low oxygen levels — unless the condition is pulmonary hypertension due to abnormal lung development in children (confirm with trial site).
People whose pulmonary hypertension is classified as WSPH Group 5, which generally refers to high lung blood pressure with unclear or mixed causes (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 301-565-3004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04071327

Sponsor: Pulmonary Hypertension Association, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 301-565-3004

More information: https://clinicaltrials.gov/study/NCT04071327

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any age are welcome to participate.
Written consent to take part in the trial must be provided (for children, a parent or guardian would typically provide this).
People who have been diagnosed with pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH), or pulmonary hypertension in children caused by abnormal lung development.
People who have had their first outpatient appointment at a Pulmonary Hypertension Care Centre within the last 6 months.

Who may not be able to join:

People whose pulmonary hypertension is classified as World Symposium on Pulmonary Hypertension (WSPH) Group 2, which generally refers to high lung blood pressure caused by left-sided heart disease (confirm with trial site).
People whose pulmonary hypertension is classified as WSPH Group 3, which generally refers to high lung blood pressure caused by lung disease or low oxygen levels — unless the condition is pulmonary hypertension due to abnormal lung development in children (confirm with trial site).
People whose pulmonary hypertension is classified as WSPH Group 5, which generally refers to high lung blood pressure with unclear or mixed causes (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Pulmonary Hypertension Association, Inc.

Registry

ClinicalTrials.gov

Start date

1 October 2015

Est. completion

1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of PAH and CTEPH patients completing all guideline-recommended diagnostics; Impact of clinical predictors of disease worsening on patient outcomes; Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov